Top stocks making the biggest move: Deere, Airbnb, AutoNation, Moderna and more.

Here are the stocks making the biggest move:

‍

Deere: Analysts surveyed by Refinitiv anticipated profits per share of $5.57 for the first quarter of the company's fiscal year. Thus the company's first-quarter earnings per share of $6.55 exceeded expectations. As opposed to the predicted $11.28 billion, the agricultural machinery manufacturer's revenue was $11.4 billion.

‍

Airbnb: Shares of the vacation rental firm fell 8.13% a day after gaining 13.35 % in response to a better-than-anticipated fourth-quarter earnings report. Several Wall Street analysts maintained a cautious stance on the company, noting competition and slower-than-anticipated customer acceptance of alternate lodgings.

‍

Albemarle: The specialty chemicals company's stock dropped 9.67% a day after rising nearly 5%. Wednesday after the closing bell, Albemarle posted better-than-expected adjusted profits per share and sales in line with StreetAccount's forecasts.

‍

Bio-Rad Laboratories: Shares increased 5.99% after the business announced a net income of $827.7 million for the fourth quarter, compared to a loss for the same time in the preceding year. Moreover, the company's non-operating margin improved to 17.4% from 15.7% in the prior year's comparable quarter. Nevertheless, profits and sales fell short of Wall Street projections.

‍

Zebra Technologies: The stock price declined 3.26% as the company forecasted a small decline in sales for the entire year. Anders Gustafsson, the chief executive officer, stated that he is adopting a "conservative approach" to the future based on an uncertain macroeconomic situation. Yet, Zebra's fourth-quarter earnings and revenue exceeded Wall Street expectations.

‍

AutoNation: The auto dealer's shares increased by 11.35% after the business surpassed fourth-quarter profit and sales estimates. AutoNation reported adjusted profits per share of $6.37, compared to the forecast of $5.83 by Refinitiv. It's $6.7 billion in revenue is above the $6.52 billion forecast.

‍

DraftKings: DraftKings' fourth-quarter earnings are above analyst forecasts, causing the stock price to increase by 15.33%. The sports wagering business lost 53 cents per share on $855 million in revenue. Analysts surveyed by Refinitiv anticipated a loss of 59 cents per share on $800 million in revenue.

‍

Moderna: The biotech stock fell 3.31% after the influenza vaccine candidate's clinical trials yielded mixed results.

‍

Redfin: Even after Redfin announced better-than-anticipated fourth-quarter results, the company's stock declined by 6.55 percent. The real estate corporation posted a loss of 57 cents per share on revenue of $480 million. Refinitiv's average forecasts indicated that analysts anticipated a loss of $1.08 per share on $445 million in revenue. Yet, income fell annually.

‍

Roku: Shares of the streaming gadget manufacturer lost early gains despite Wall Street's broader decline. The stock began trading higher after Bank of America upgraded it to buy from underperform, stating that Roku is on the way to sales and margin improvement. It finished with a loss of 1.4%.

‍

DoorDash: The food delivery company's stock slumped 7.59% after reporting a mixed fourth quarter. DoorDash announced quarterly sales of $1.82 billion, above the $1.77 billion that Refinitiv projected, and issued an optimistic forecast. Yet, the company's loss per share of $1.65 exceeded expectations by more than thrice.

‍

Biogen: Shares of the biopharmaceutical business increased 2.52% after Japanese drugmaker Eisai stated that it anticipates FDA approval of its Alzheimer's medication Leqembi this summer. Biogen and Eisai developed the medication together.

‍